Dr. Alessandro Passardi is a medical oncologist, chief of the Day Hospital Unit, and a member of the Gastrointestinal Unit at IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Dino Amadori, Meldola, Italy. He served as an assistant oncology at the Ospedale Morgagni-Pierantoni from 2005 to 2008. He deals with clinical and translational research in gastrointestinal cancers, particularly colorectal cancer. The research areas he deals with mostly include clinical trials with new therapeutic regimens or strategies, the search for predictive markers of response and resistance to targeted treatments, the pathway of angiogenesis, and liquid biopsies.